ADNT Stock Recent News

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Adient (ADNT) envisions fiscal 2023 revenues and adjusted EBITDA of $15.4 billion and $920 million, up from the prior guidance of $15 billion and $850 million, respectively.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Adient (ADNT) reported earnings 30 days ago. What's next for the stock?

Adient's (ADNT) second-quarter 2023 earnings lag estimates owing to weaker-than-expected EBITDA from the Americas segment.

Adient plc (NYSE:ADNT ) Q2 2023 Earnings Conference Call May 3, 2023 8:30 AM ET Company Participants Mark Oswald - Vice President, Investor Relations and Corporate Communications Doug Del Grosso - President and Chief Executive Officer Jerome Dorlack - Executive Vice President and Chief Financial Officer Conference Call Participants Emmanuel Rosner - Deutsche Bank John Murphy - Bank of America Rod Lache - Wolfe Research Colin Langan - Wells Fargo James Picariello - BNP Paribas Operator Welcome to the Adient Second Quarter Financial Results Conference Call. Your lines have been placed on a listen-only mode until the question-and-answer session.

The headline numbers for Adient (ADNT) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Adient (ADNT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.